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Recognition of the Peripheral Self by Naturally
Arising CD25 CD4 T Cell Receptors
unknown. Furthermore, the relationship between the TR
and CD25 TCR repertoires is unclear (Shevach, 2002).
Information on the antigen specificity of TR TCRs is
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2 Howard Hughes Medical Institute class II complexes in an avidity range between positive
and negative selection (reviewed in Maloy and Powrie,Department of Immunology
3 Department of Biostatistics 2001). This view is based primarily on a single TCR
transgenic model of TR development where the cognate4 Department of Comparative Medicine
University of Washington peptide was also expressed as a transgene (Jordan et
al., 2001). In this experimental system, a high level ofSeattle, Washington 98195
peptide expression resulted in the deletion of TCR trans-
genic T cells, whereas a moderate level resulted in partial
deletion, with up to 50% of the remaining peripheralSummary
T cells expressing CD25 and exhibiting functional prop-
erties resembling naturally arising TR. This model wouldNaturally arising CD25 CD4 regulatory T cells (TR)
play an important role in the prevention of autoimmu- therefore predict that the CD25 and CD25 TCR reper-
toires are distinct and that the former is comprised ofnity. TCR specificity is thought to play a critical role
in TR development and function, but the repertoire and self-reactive TCRs.
However, one potentially serious caveat of the abovespecificity of TR TCRs remain largely unknown. We find
by sequencing of TRAV14 (V2) TCR chains associ- experiments is that the transgene-enforced high-affinity
TCR recognition of cognate peptide may not representated with a transgenic TCR chain that the TR and
CD25 CD4 TCR repertoires are similarly diverse, yet the mechanism by which naturally arising TR develop.
For example, this high-affinity TCR signal may mimiconly partially overlapping. Retroviral expression of
TCR genes in TCR transgenic RAG-deficient T cells unknown “non-TCR”-mediated signals, such as cyto-
kines, required for naturally arising polyclonal TR devel-revealed that a high frequency of TCRs derived from
CD25 but not CD25 CD4 T cells confers the ability opment. Recent papers have further questioned the
applicability of this model to naturally arising TR. First,to rapidly expand upon transfer into a lymphopenic
host. Thus, these data show that a large proportion it has been demonstrated that naturally arising CD25
TR can recognize foreign antigens such as 2,4-dinitroflu-of naturally arising TR have substantially more efficient
interactions with MHC class II bound peptides from orobenzene (Dubois et al., 2003), Candida albicans
(Montagnoli et al., 2002), and Leishmania major (Belkaidthe peripheral self than CD25 T cells.
et al., 2002). Second, at least some peripheral CD25
T cells can be converted into CD25 T cells with regula-Introduction
tory properties in both human (Walker et al., 2003b) and
murine (Chen et al., 2003; Thorstenson and Khoruts,Naturally arising CD25 CD4 regulatory T cells (TR) play
an important role in the preservation of self-tolerance 2001) models. Last, recent attempts to evaluate TR self-
reactivity utilizing in vitro limiting dilution or in vivo CFSEby suppressing autoreactive T cells in the periphery
(reviewed in Maloy and Powrie, 2001; Sakaguchi, 2000; dilution assays were confounded by the sensitivity of
the assays and by the heterogeneity of T cells in regardsShevach, 2002). Several lines of evidence suggest that
TR development and function hinges upon a particular to expression of adhesion molecules, cytokine recep-
tors, etc. (Fisson et al., 2003; Romagnoli et al., 2002).TCR specificity. First, TR do not develop in TCR trans-
genic mice lacking RAG genes (Itoh et al., 1999), sug- Thus, the question of self-reactivity within the naturally
arising CD25 TR population remains unresolved.gesting that only cells with certain TCR specificities can
develop into TR. Second, TCR engagement is required In order to directly address this issue, we analyzed
for TR suppression in both in vitro (Takahashi et al., 1998; the TCR repertoires of naturally arising CD25 and
Thornton and Shevach, 1998) and in vivo (Apostolou et CD25 T cell subsets and tested their ability to interact
al., 2002; Klein et al., 2003) models. Thus, there are with self-peptide:MHC class II complexes. For our stud-
abundant data demonstrating that TCR recognition of ies, we utilized the TCR repertoire represented by vari-
specific ligands is critical for naturally arising TR develop- able TRAV14 (V2) TCRchains paired with a fixed TCR
ment and function. chain. We find by sequencing that the TR and CD25
In contrast, there are only sparse data characterizing TCR repertoires are diverse and only partially overlap-
the TCR repertoire of regulatory T cells. It appears that ping. The specificity of the cloned TR TCRs was then
TR utilize a polyclonal TCR repertoire that is not severely analyzed both in vitro and in vivo by retrovirus-mediated
restricted, as V and V usage is similar between CD25 expression in mono-specific TCR transgenic RAG-
and CD25 CD4 T cells (Takahashi et al., 1998). How- deficient T cells. Using this approach, we demonstrate
ever, the actual diversity of the TR TCR repertoire is that a large proportion of naturally arising TR TCRs rec-
ognize constitutively presented peripheral self-antigens
with higher efficiency than CD25 TCRs.*Correspondence: aruden@u.washington.edu
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chain should not adversely affect CD25 T cell develop-
ment. This notion is supported by numerous observa-
tions in TCR transgenic mice that functional TR develop
only with the expression of endogenous TCR chains
(Apostolou et al., 2002; Itoh et al., 1999; Thornton and
Shevach, 2000). As TCR allelic exclusion is very effi-
cient, these data strongly suggest that the endoge-
nously rearranged TCR chains are largely responsible
for the antigen specificity and development of TR when
paired with the transgenic TCR chain.
We sequenced over 600 TRAV14 TCR clones iso-
lated from the CD25 and CD25 subsets in two inde-
pendent experiments (Table 1). Pooled T cells from two
mice were used for each experiment. TCR sequences
were analyzed by IMGT-V-QUEST (IMGT, the interna-
tional ImMunoGeneTics information system, at http://
imgt.cines.fr; initiator and coordinator, Marie-Paule Le-
franc, Montpellier, France). Twelve different subregions
of TRAV14 and 41 distinct J regions were found in these
TCR sequences. Interestingly, there was some consis-
tent skewing in both TRAV14 subtype and J region usage
between the TR and CD25 subsets (Figure 2A). For
example, TRAJ7 was 6-fold more common in CD25
T cells, whereas TRAV14-2*02 was 2-fold more common
in CD25 T cells. Although there were a number of simi-
larities between the TR and CD25 subsets, these resultsFigure 1. Experimental Strategy
hinted at substantial differences in the TCR repertoires
TCR transgenic mice develop naturally arising CD25 CD4 T cells
of TR and CD25 CD4 T cells.that are anergic/hypoproliferative and suppressive upon TCR liga-
To further explore this possibility, we analyzed TCRtion. Because the TCR chain is fixed, the TCR repertoire can be
CDR3 amino acid sequences, as this region of the TCRanalyzed by cloning and sequencing only the endogenously re-
arranged TCR genes from CD25 or CD25 CD4 TCli TCR trans- makes the greatest contribution to antigen specificity.
genic T cells. As the mice are on a TCR/ background, only one Initial examination of the CDR3 length revealed a
TCR is expressed per T cell. TCR genes can then be retrovirally Gaussian distribution, primarily in the range of 10 to 13
expressed in CD25 CD4 -TCR transgenic  RAG1/ T cells,
amino acids for both the TR and CD25 subsets (Figurerecreating the original TCR. TCR signaling in the recipient CD25
2B). Furthermore, the distribution of the number of TCRsT cell should result in conventional T cells responses such as prolif-
with a unique CDR3 sequence appeared to be statisti-eration, irrespective of the origin of the transferred TCR.
cally similar between the CD25 and CD25 subsets
(Table 2). These data therefore suggest that both sub-
Results
sets have a diverse TCR repertoire displaying few pre-
dominant clones.
The TR and CD25 CD4 TCR Repertoires Are To estimate the total number of unique TCR se-
Diverse and Show Only Limited Overlap quences at the CDR3 level, we utilized previously de-
Previous studies have not found any differences in V or scribed statistical approaches for evaluating the diver-
V gene usage between the CD25 and CD25 subsets sity of biological species (ACE) or TCRs (MLE) from a
(Takahashi et al., 1998). However, it is unknown whether random sampling (Casrouge et al., 2000; Colwell, 1997).
TR have a limited or unrestricted TCR repertoire and These statistical approaches also suggest that the TR
whether this repertoire is distinct from, or largely over- TCli- TCR repertoire is as diverse as the CD25 reper-
lapping with, the CD25 CD4 TCR repertoire. To ad- toire, containing an estimated 125–300 unique TRAV14
dress these questions, we investigated the TCR reper- CDR3s at the amino acid level (Table 1).
toire displayed by TRAV14 (V2) CD4 T cells in TCli Any number derived from an approach based on ran-
TCR transgenic mice (Figure 1). These T cells represent dom sampling may be an underestimate if the CD25
10% of both the peripheral CD25 and CD25 subsets. and/or CD25 T cell populations contain an infrequent
In previous work, we found that significant numbers of yet very diverse subset of TCRs. Nevertheless, the
TR develop in these transgenic mice only in the presence equivalent diversity observed between the CD25 and
of endogenous TCR rearrangement (Gavin et al., 2001). CD25 TCRs is unlikely to result from an artifact of our
To exclude from our analysis two productively re- cloning strategy for several reasons. First, the use of
arranged TCR genes expressed in a single cell, we used bulk PCR-based techniques for estimating TCR diversity
TCli TCR transgenic mice heterozygous for the C null has been previously validated (Casrouge et al., 2000).
mutation (Mombaerts et al., 1992). We believe that fixing Second, we utilized over 4-fold more CD25 than CD25
the TCR chain to study the TR TCR repertoire is a valid T cells for mRNA isolation, indicating that the amount
approach for the following two reasons. First, limiting of starting material should not limit the observed diver-
the TCR repertoire in this manner has been invaluable for sity of the CD25 TCR library relative to the CD25
direct TCR repertoire analysis by sequencing (Correia- library. Third, the abundance coverage estimator (ACE)
appeared to reach a plateau when plotted as a functionNeves et al., 2001). Second, the use of a single TCR
Self-Reactivity of CD25 CD4 TCRs
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Table 1. Summary of TRAV14 TCR Sequence Sets and Analysis of Diversity Using CDR3 a.a. Sequence to Identify Unique TCRs
Total No. of No. of Unique Estimated No. of Unique Estimated No. of Unique
Sequences CDR3 a.a. CDR3s in Original Popl. CDR3s in Original Popl.
Experiment Source Sampled (n) Sequences (M) (ACE N) (MLE  N (95% CI))
1 CD25 127 94 285 198 (158,281)
CD25 123 82 270 138 (116,186)
2 CD25 149 108 346 217 (177,293)
CD25 148 87 297 125 (108,154)
TCR chains were cloned and sequenced from purified CD25 or CD25 CD4 T cells as described in the text. The estimated number of
total unique sequences (N) is derived from an abundance coverage estimator (ACE, calculated by the EstimateS program [Colwell, 1997]),
which is based on the probability of sampling a particular species multiple times and thus derived from Table 2, or the MLE, which is based
only on the number of unique sequences in the sample set (M) shown in this table and has been previously used to estimate TCR diversity
(Casrouge et al., 2000). Both the ACE and MLE are based on the probability that random sampling would generate the observed distribution
of singletons, doubletons, and so forth, of distinct isolates. However, the ACE, unlike the MLE, does not assume that all individual species
are equally distributed. We considered a particular CDR3 amino acid sequence a unique “species” for this purpose.
of the size of the TCR sample set (data not shown), are in the range of previous reports using limited TCR
repertoire T cells (Correia-Neves et al., 2001). Takensuggesting that the number of TCRs sequenced is ade-
quate to reach the semiquantitative conclusion that the together, the data on the distribution of TCRs (Table 2)
and the direct estimation of the TCR population (TableTCR repertoire of CD25 and CD25 CD4 T cells are
comparably diverse. Last, our estimates of TCR diversity 1) argue for a remarkable diversity within the CD25
Figure 2. The TR TRAV14:TCli- TCR Reper-
toire Only Partially Overlaps with the CD25
CD4 Repertoire
TRAV14 TCR genes were isolated by RT-
PCR from CD25 and CD25 T cells purified
from two TCli-TCR  TCR/ mice as de-
scribed in the Experimental Procedures on
two different occasions to generate two inde-
pendently derived CD25 and CD25 TCR
libraries. TCR gene sequences were ana-
lyzed by IMGT-V-QUEST.
(A) TRAV14-subtype and J region usage by
CD25 and CD25 T cells. Data shown are
for V subtypes and J regions with a greater
than 5% and 2% frequency, respectively. Re-
sults of two independent experiments are
shown. ND (not determined) refers to se-
quences for which IMGT did not identify a
TRAJ region.
(B) CDR3 length distribution as determined
by IMGT-V-QUEST.
(C) Similarity Index analysis suggests that the
TR and CD25 TCR repertoires overlap by less
than25%. The Jaccard index is an estimate
of the similarity between two sample sets
(Cj  number of common species/number of
total species observed). The number of oc-
currences of each sampled species is not
considered. For this purpose, an individual
TCR species is defined by its unique CDR3
amino acid sequence. By comparing the first
half of each CDR3 sequence sample set with
the second half, we obtained an empiric index
value for sample sets that should be identical
(0.15). We then compared the first half of
each set with the first half of other sets, as
well as the second half with the second half.
The average Jaccard index of 0.025 be-
tween CD25 and CD25 sets isolated at the
same time, in combination with data from the
Morisita-Horn index calculations (Supple-
mental Figure S1), suggests that the TR and
CD25 TCR repertoires overlap semiquanti-
tatively by25%. Jaccard and Morisita-Horn
indexes were calculated using the statistical
package EstimateS (Colwell, 1997).
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Table 2. Frequency of Individual TCRs with Unique CDR3 Amino Acid Sequences
No. of Unique CDR3 Sequences at Given Frequency
No. of Times an Individual Experiment 1 Experiment 2
CDR3 a.a. Sequence Is Found
within a Sequenced Set CD25 CD25 CD25 CD25
1 72 63 83 65
2 17 8 15 9
3 1 5 8 6
4 2 2 2





The distribution of TCRs between the CD25 and CD25 subsets within an experiment are statistically comparable, suggesting similar diversity,
as assessed by Fisher’s Exact Test. This approach allows for an evaluation of relative diversity without attempting to directly assess the
number of species within the given population and provides exact p values in finite samples. The p values of 0.20 and 0.58 obtained for
Experiments 1 and 2, respectively, are consistent with the null hypothesis that the two distributions are the same, suggesting an equivalent
or comparable diversity between the CD25 and CD25 subsets.
TCR repertoire, which appears to be comparable to the subset. Finally, we utilized two different statistical esti-
mators of similarity between two populations. One ofCD25 TCR repertoire.
Next, we tested the degree of overlap between the TR these estimators, the Jaccard similarity index, provides
an estimate of overlap between two TCR repertoiresand CD25 TCR repertoires. First, we asked whether
TCRs present at high frequency in the CD25 sample independently of the number of repeat sequences ob-
served within each subset (Figure 2C). In contrast, theset were equally represented in the corresponding
CD25 set, and vice versa (Table 3). We found that the Morisita-Horn index incorporates both unique and re-
peat sequence information (Supplemental Figure S1 atvast majority of these TCRs were asymmetrically distrib-
uted between the CD25 and CD25 subsets. This find- http://www.immunity.com/cgi/content/full/21/2/267/
DC1). Nevertheless, both approaches provide compara-ing is further supported by the lack of overlap between
sequences found in both TR TCR sets (n  11) and ble semiquantitative estimates of a less than 25% over-
lap between the TR and CD25 TCR repertoires. A logicalsequences found in both CD25 TCR sets (n 19). We
reasoned that sequences found in both independently implication of this finding is that certain TCR sequences
may skew T cell development toward the TR or CD25derived TR or both CD25 TCR libraries should best
represent the TCR repertoire of the respective T cell phenotype, and the question arises as to the role of TCR
specificity in TR immunobiology.
Table 3. Distribution of TCR Chains Found at High Frequencies TR, but Not CD25, CD4 T Cells, Contain
a High Frequency of Self-Reactive TCRsUnique TCR
Next, we investigated the functional implications of theClone CD25 CD25
differences observed between the TR and CD25 TCR
Experiment 1 repertoire by sequencing. A hallmark of naturally arising
G69 5 0 CD25 CD4 T regulatory cells is their inability to prolif-
G25 5 0 erate or produce IL-2 upon TCR stimulation in vitro
R19 4 0 (Gavin et al., 2001; Takahashi et al., 1998; Thornton and
R18 4 0
Shevach, 1998). This property of TR hinders the studyB31 2 5
of their TCR specificity. To overcome this problem, weL35 0 4
retrovirally transferred TR TCR chains into conventionalL69 0 4
L33 0 5 CD25 CD4 recipient T cells (Figure 1). We reasoned
B33 0 5 that activation through the transferred TR TCR should
B2 0 6 elicit conventional responses in the transduced T cells,
such as proliferation.Experiment 2
We chose TCli-  RAG1/ (V18, V6) mice de-G8 5 0
scribed above as the source of conventional CD25G43 7 4
CD4 T cells. These T cells have a single defined speci-B2 0 4
B54 1 5 ficity to a foreign antigen, human CLIP, and do not ex-
B15 1 5 press endogenous TCR chains. Upon retroviral trans-
B33 0 7 duction of these cells, the level of retroviral LTR-driven
B8 1 8 TRAV14 TCR expression was comparable to that of
B5 1 14
endogenous TCR expression in TCli-  RAG1/
TCR clones in italics were tested individually in experiments de- T cells (Supplemental Figure S2) and stable upon adop-
scribed in Figure 5. TCR clones found at 3% frequency are tive transfer into lymphopenic hosts for up to 3 months
shown.
(data not shown).
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Figure 3. TR TCRs Are Self-Reactive: Acqui-
sition of TR TCRs Results in Rapid In Vivo
Expansion and Wasting Disease
TCli -TCR  RAG1-deficient CD4 T cells
were retrovirally transduced with MigR1
“empty” vector or with TRAV14 TCR libraries
derived from CD25 or CD25 CD4 T cells.
Three days after in vitro activation, 106 T cells
were adoptively transferred into TCR-defi-
cient hosts by intravenous injection. Trans-
duction efficiency was approximately 1% for
all conditions in this experiment.
(A) Expansion of TCR-transduced T cells.
The relative expansion of transduced T cells
was assessed as the percentage of V2 or
GFP cells within the adoptively transferred
V6 T cell population in the peripheral blood
and the spleen at the times indicated (top).
The size of the adoptively transferred popula-
tion is also shown as the percentage of V6
T cells in the peripheral blood or spleen
(middle). Last, the absolute numbers of trans-
duced T cells residing in the spleen are cal-
culated based on flow cytometric analysis
(bottom). Each point represents data from an
individual mouse (“empty” vector n  4,
CD25 n  7, CD25 n  6), with half of the
group harvested at 5 or 9 weeks.
(B) Expansion of T cells expressing CD25
TCR chains causes wasting disease. The
ratio of the starting weight of recipient mice
is shown 	 SEM (“empty” vector n  2,
CD25 n  4, CD25 n  3). Weight loss was
associated with gross pathologic findings of
colon inflammation, including bowel wall
thickening, poorly formed stool, and shorten-
ing of the colon (data not shown).
Using this retroviral transduction system, we directly transduced with “empty” vector showed little relative
expansion (Figure 3A). T cells transduced with CD25tested the hypothesis that TR TCRs have a higher avidity
for self-antigens than CD25 TCRs by assessing the TCR’s also expanded, but with significantly delayed
kinetics in comparison to T cells expressing TR TCRs.ability of these TCRs to confer the capacity to expand
in vivo in syngeneic lymphopenic hosts. For these exper- Expression of some self-reactive TCRs within the CD25
subset is not surprising as it has been well documentediments, we intentionally chose retroviral infection condi-
tions that resulted in a low transduction efficiency to previously (Powrie et al., 1993; Sakaguchi et al., 1995).
Increases in total T cell numbers correlated with themaximize the dynamic range of relative expansion of
transduced versus nontransduced T cells. Since we did relative expansion of the transduced T cells. Of note,
we did not find substantial expansion of “empty” vector-not know a priori the avidity of naturally arising CD25
TCRs for self-peptide:MHC class II complexes, we se- transduced T cells, suggesting that the TCli TCR does
not facilitate strong homeostatic expansion. In additionlected T cell expansion in lymphopenic hosts as the
most sensitive assay for in vivo assessment of self- to conferring the ability to expand in vivo, TR TCR expres-
sion resulted in wasting disease reflected by weightreactivity. It has been shown for naive and memory
T cells that the rate and extent of homeostatic expansion loss during the course of the experiment (Figure 3B). In
contrast, expression of CD25 TCRs or “empty” vectorin lymphopenic hosts is dependent upon the relative
avidity of TCR for self-peptide:MHC class II complexes, did not result in weight loss. Taken together, these data
suggest that at the population level, TR TCRs have sub-including that of nonpathogenic TCR-ligand interactions
(Kassiotis et al., 2003; Moses et al., 2003). stantially more efficient interactions with self-pep-
tide:MHC class II complexes in comparison with CD25For our initial experiments, we transduced complex
structures of TCRs from TR or CD25CD4T cell-derived CD4 TCRs. Because the self-peptide ligands for CD25
TCRs have not been identified, these TCRs may eitherTRAV14 TCR libraries. On day 3 after in vitro activation,
we adoptively transferred the population containing have increased affinity for self-peptide:MHC class II
complexes and/or recognize more abundant self-pep-both transduced and nontransduced TCli- RAG1/
T cells into TCR/ hosts to assess the relative expan- tides, which would collectively result in an increased
avidity for self ligands.sion in vivo of T cells expressing the retroviral TCR. We
found a striking expansion of T cells transduced with Consistent with the ability of T cells expressing TR
TCRs to cause pathologic weight loss, in vitro analysisTR TCRs relative to the cotransferred nontransduced
T cells as early as day 8 after transfer, while T cells of these T cells isolated from the recipient mice showed
Immunity
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Figure 4. A Pool of 10 TR TCRs Recognize
Peripherally Presented Self Antigen:MHC
Class II Complexes with Higher Avidity than
10 CD25 TCRs
(A) Analysis of a pool of 10 CD25 or CD25
TCR chains (Supplemental Table S1) shared
between both independently derived CD25
TCR libraries or both CD25 TCR libraries,
respectively. TCli -TCR  RAG1-deficient
T cells were retrovirally transduced with TR or
CD25 TCR genes in MigR1-MG (without
IRES-GFP), or “empty” vector MigR1. Two
days later, 4  105 T cells were adoptively
transferred into RAG1-deficient hosts for 11
days. The percentage of transduced T cells
in the population adoptively transferred was
normalized to a fixed value (between 3% and
6%) using concurrently activated nontrans-
duced TCli -TCR  RAG1-deficient trans-
genic T cells. Expansion of T cells expressing
transduced TCRs (the percentage of V2 or
GFP cells within the V6 CD4 T cell popu-
lation, top) and the total percentage of trans-
ferred T cells in the spleen (% V6 CD4,
middle) was assessed by flow cytometry.
Bottom panels show representative FACS
plots of the graphed data. Two independent
experiments are shown. Each symbol repre-
sents relative cell expansion in a single re-
cipient.
(B) CD25 TCR recognition of self pep-
tide:MHC class II complexes is required for
in vivo expansion. TCli -TCR RAG1-defi-
cient T cells were retrovirally transduced as
above. Two days later, 4  105 T cells were
adoptively transferred into TCR-deficient or
TCR  Ii  H-2M triple-deficient hosts for
12 days before assessment of expansion of
transduced T cells in the spleen by flow cy-
tometry as the percentage of V2 or GFP
cells within the total transferred CD4 V6
T cell population. The percentage of trans-
duced T cells in the adoptively transferred
population was normalized to 2.33% or 5%
using concurrently activated nontransduced
TCli -TCR  RAG1-deficient T cells.
that they were neither anergic nor suppressive (data not found that the TR TCR pool conferred the capacity to
expand in RAG1-deficient mice when transduced intoshown). There was also no expression of CD25 by T cells
transduced with either TR or CD25 TCR’s at the time TCli-  RAG1/ T cells (Figure 4A). Similar T cell
expansion conferred by CD25 TCRs was also observedof analysis (data not shown). Thus, at a population level,
acquisition of TR TCR specificity by activated conven- in TCR-deficient mice, but not in TCR  Ii  H-2M
triple deficient recipients (Figure 4B), which display ational CD25T cells is not capable of conferring a TR phe-
notype. greatly diminished repertoire of self-peptide:MHC class
II complexes (Kovats et al., 1998). Thus, the observedThe rapid in vivo expansion of T cells transduced with
TR TCRs suggested that the frequency of self-reactive expansion of CD25 TCR expressing TCli-RAG1/
T cells is dependent upon recognition of self-pep-TCRs was high. To directly test this hypothesis, we de-
cided to analyze a pool of only 10 unique TCR chains tide:MHC class II complexes. Notably, we did not ob-
serve substantial in vivo expansion of T cells expressingfrom the TR or CD25 subset. For these experiments,
we selected TCR chains shared between the two inde- the pool of CD25 TCRs, suggesting that the frequency
of self-reactive CD25 TCRs responsible for in vivopendently derived TR TCR sequence sets or the two
CD25 TCR sets. We reasoned that utilization of these expansion observed with a complex set of TCRs, as
shown above in Figure 4A, is quite low. Thus, these dataTCRs is reliably skewed toward the TR or CD25 T cell
subsets and that the CD25 TCRs are therefore less confirmed that CD25 TCRs have increased avidity for
self ligands compared with CD25 TCRs.likely to be contaminated with TCRs derived from acti-
vated CD25 CD4 T cells. These TCRs were diverse We then analyzed the individual TCRs in these pools.
We did find that certain TCRs were poorly recognizedand not dominated by a particular sequence motif at
the TRAV, TRAJ, or CDR3 level (Supplemental Table by the V2 monoclonal antibody, presumably due to
their TRAV14 subtype. Thus, additional TCRs were in-S1). Using the same retroviral transduction protocol, we
Self-Reactivity of CD25 CD4 TCRs
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Figure 5. A High Frequency of Individual TR,
but Not CD25, TCRs Recognize Self Pep-
tide:MHC Class II Complexes with In-
creased Avidity
TCRs used in Figure 4 were individually
tested using the same approach. Because
some of these TCRs were poorly recognized
by the V2 antibody, an additional CD25 and
3 additional CD25 TCRs were also analyzed
to make a group of 10 individual TCRs tested
for each subset (Supplemental Table S1). The
plots summarize data from eight different ex-
periments, with each symbol representing
data from a single recipient. In every experiment, T cells transduced with the pool of CD25 TCRs were used as the positive control and with
“empty” vector as the negative control. To normalize the expansion of transduced T cells between experiments, we used the following formula:
relative expansion  (% experimental  % “empty” vector)/(% CD25 pool  % “empty” vector). Thus, expansion equivalent to the pool of
10 CD25 TCRs would give a value of 1, and no expansion a value of 0. The dashed line at 0.2 represents the upper limit of variability found
in the “empty” vector controls. Application of the nonparametric Wilcoxon Rank Sum Test to the mean relative expansion for each TCR
demonstrates that the differences observed between the groups of CD25 and CD25 TCRs tested are statistically significant (p 
 0.009).
cluded in the analysis such that a total 10 CD25 and 11 day period or more in a lymphopenic environment
favoring cell growth. Thus, these data suggest that a10 CD25 TCRs were tested individually (Supplemental
Table S1). Remarkably, we found that approximately sizable subset of TR can recognize ubiquitously pre-
sented self antigens, which is further supported by our60% (6/10) of TR TCRs tested were capable of conferring
some ability to expand in vivo (Figure 5). Four of these finding that 10%–20% of normal polyclonal CD25 TR
maintain CD25 expression in response to autologousTCRs reproducibly led to a rapid expansion, whereas
the remaining two conferred only a modest expansion APCs in vitro (Supplemental Figure S4).
of transduced T cells in some of the recipient mice. In
contrast to the TR TCRs, only 1 of 10 CD25 TCRs Self-Reactive CD25 TCRs Skew CD4 T Cell
Development or Survival towardshowed any sign of self-reactivity in 2 of 5 recipients.
None of the CD25 TCRs showed the ability to confer the CD25 Phenotype
Both the in vitro and in vivo data directly demonstraterapid in vivo expansion in all recipient mice. Thus, these
data directly demonstrate that naturally arising CD25, that a large percentage of TCRs derived from CD25
T cells interact with self ligands with greater avidity thanbut not CD25, T cell populations display a high fre-
quency of TCRs with higher avidity for peripheral self- the TCRs derived from CD25T cells (Figures 3–5). How-
ever, it can not be ascertained from this data what theantigens.
functional implications of these differences in self-reac-
tivity are. We hypothesized that the observed increaseCD25 TCRs Can Recognize Self Peptides
Presented by Splenic APCs in self-reactivity of CD25-derived TCRs would skew
T cell development toward the CD25 phenotype, whichExpansion of T cells bearing TR TCRs in vivo may result
from TCR interaction with tissue-specific or ubiquitously would be consistent with studies using TCR transgenic
mice (Jordan et al., 2001; Klein et al., 2003; Walker etpresented antigens. Previous indirect studies have sug-
gested the existence of naturally arising tissue-specific al., 2003a) and with our sequencing data suggesting
that the CD25 and CD25 TCR repertoires are onlyTR (Seddon and Mason, 1998; Taguchi et al., 1994) but
do not exclude the possibility of TR responsive to ubiqui- partially overlapping (Figure 2C; Supplemental Figure
S1). Thus, we retrovirally transduced TRAV14 TCRtously expressed antigen. Thus, we tested whether TR
TCRs could recognize self peptides presented on chains into TCli TCR transgenic hematopoetic bone
marrow (BM) progenitors, which were adoptively trans-splenic APCs. We found that only T cells retrovirally
transduced with TR, but not CD25 TCRs, proliferated ferred into lethally irradiated hosts (Figure 6). We ana-
lyzed three self-reactive CD25 TCRs (S19, R5, andin response to autologous splenic APCs (Supplemental
Figure S3A). Furthermore, these T cells also responded, G113) and three nonreactive CD25 TCRs (N11, B2, and
B8). The percentage of peripheral CD4 T cells express-albeit at a lower level, to invariant chain-deficient APCs
(Ii0), which primarily present peptides derived from en- ing the retroviral TCR appeared comparable between
the CD25 and CD25 TCRs except for S19, which wasdogenously synthesized proteins that are ubiquitously
expressed (Kovats et al., 1998). We also found reactivity decreased likely due to partial deletion. We found that
all three self-reactive CD25-derived TCRs favored theto self peptides in the limited pool of 10 TCRs found in
both independently derived TCR sets described above development or survival of CD25-expressing cells in the
peripheral lymph nodes, albeit with some variability(Supplemental Figure S3B). When tested individually,
we found that it was 1 of the 4 in vivo reactive CD25 (6%–50% CD25). In contrast, none of the three non-
self-reactive CD25-derived TCRs were capable of gen-TCRs (Figure 5) that conferred the ability to proliferate
in vitro to autologous splenic APCs (data not shown). erating any substantial numbers of CD25 T cells
(0.5%). Although further studies are required, theseThis is likely due to the relative insensitivity of the in vitro
proliferation assay, which assesses cells entering S findings suggest that the increased self-reactivity ob-
served in CD25 TCRs has functional implications forphase over an 18 hr period, in comparison with in vivo




Characterization of the TR TCR repertoire is important for
understanding the development and function of naturally
arising regulatory T cells. Here, we address this issue by
combining two previously described approaches: (1) the
use of a fixed TCR chain to limit the TCR repertoire to
allow for the analysis of TCRs at the level of individual
sequences (Correia-Neves et al., 2001; Sant’Angelo et
al., 1997); and (2) the use of retroviral transduction to
introduce TCR genes into CD4 T cells (Fujio et al.,
2000). This strategy allowed us to correlate the TR and
CD25 CD4 TCR sequence information with a func-
tional assessment of their TCR specificity.
Analysis of the TR TCR repertoire based on the sam-
pling of TRAV14:TCli-TCR TCRs by direct sequencing
of TCR chains suggested that the TR TCR repertoire is
as diverse as the CD25 repertoire at the level of CDR3
amino acid sequences. This is an unexpected finding,
as the CD25 CD4 T cell population is 5%–10% of
the CD25 population. Although further studies are
needed to extend this observation, it raises several inter-
esting issues regarding TR biology. One possible expla-
nation for equivalent TCR diversities in peripheral T cell
populations is that the postthymic selection CD25
CD4 TCR repertoire is subjected to further restriction
in the periphery due to a requirement for low-avidity
TCR interactions with self peptides bound to MHC class
II molecules. Experimental support for this notion comes
from a recent analysis of mice with a restricted TCR
repertoire, TCR minilocus mice (Correia-Neves et al.,
2001). In contrast, higher avidity interactions of TR TCRs
with self peptide:MHC class II complexes would lead to
a lesser restriction of the postthymic TCR repertoire. As
illustrated by our adoptive transfer experiments, these
peripheral TR ligands are readily available (Figures 3–5).
The equivalent diversity of TR and CD25 TCR reper-
toires also suggests that TR can recognize a wide variety
of antigens. This may reconcile our finding of increased
avidity of TR for self ligands with recent reports showing
expansion of naturally occurring TR upon recognition of,
and suppression of immune responses to, Leishmania
major and other pathogens (Belkaid et al., 2002; Montag-
noli et al., 2002).
Our sequencing data also suggest that the TR and
CD25TCR repertoires have only a minor overlap (Figure
2C; Supplemental Figure S1). Although the differences
Figure 6. Skewing of CD25 T Cell Development by TCR Specificity
between the TCR repertoires are consistent with the
(A) Analysis of CD25 and CD25 CD4 T cell subsets in bone observed enhanced self-reactivity with self ligands of
marrow chimeras expressing retrovirally transduced TCR clones
CD25, but not CD25, TCRs (Figure 5), the cause ofS19 and N11. The CD25-derived clone S19, but not the CD25-
the overlap between these two TCR repertoires is lessderived clone N11, was found to confer in vivo self-reactivity in
experiments similar to those shown in Figure 4 (data not shown). clear. This overlap is unlikely to result from a contamina-
These TCR genes were retrovirally transduced into TCli TCR- tion during cell isolation, as the purity was 95%
bone marrow and adoptively transferred to lethally irradiated RAG1- and 98% for the CD25 and CD25 subsets, respec-
deficient mice as previously described (Gough and Raines, 2003). tively. Alternatively, it may be explained by the presence
After 6 weeks, expression of CD25, GFP, and V2 was assessed
by flow cytometry of axillary and inguinal lymph node cells. Cells
analyzed were gated for CD4 expression. T cells expressing the
retroviral TRAV14 TCR gene co-express GFP present in the MigR1
B8 (Figure 5) were individually transduced into TCli- transgenicvector. Similar results were obtained by flow cytometric analysis of
splenocytes from chimeric mice (data not shown). bone marrow as above. The percentage of CD25 expressing retro-
virally transduced V2 GFP CD4 T cells from the axillary and(B) Analysis of CD25 and CD25 CD4 T cell subsets in bone marrow
chimeras expressing retrovirally transduced TCR clones R5, G113, inguinal lymph nodes 6 weeks after bone marrow reconstitution is
shown (	SEM). Data are pooled from two independent experimentsB2, and B8. The self-reactive CD25-derived TCR clones R5 and
G113 and the non-self-reactive CD25-derived TCR clones B2 and (R5 n  6, G113 n  3, B2 n  5, B8 n  2).
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of recently activated CD25 T cells in the CD25 subset, development or allowing precommitted regulatory T cells
to expand or survive.or the presence of regulatory T cells in both CD25 and
CD25 subsets, such as GITR CD25 regulatory T cells While our experiments confirmed the ability of TR TCRs
to recognize self antigens, we observed a substantial(Uraushihara et al., 2003). However, this is an unlikely
possibility as our preliminary analysis of GFP-Foxp3 fu- variation in the efficiency of interaction with self ligands
among individual TCRs (Figure 5). Although a large pro-sion protein knockin mice revealed that more than 95%
of CD25 CD4 T cells express Foxp3 within the gate we portion (4/10) of these TCRs was strongly self-reactive
in vivo, the others were only intermittently and moder-used for sorting (J.D. Fontenot and A.Y.R., unpublished
observations; data not shown). This suggests that our ately self-reactive or nonreactive as measured by T cell
expansion in lymphopenic hosts. One possible interpre-FACS-sorted CD25 T cell populations contain very few
nonregulatory T cells. tation of this result is that the latter TCR group falls into
the lower range of TR TCR avidity for self ligands thatAnother likely cause for the overlap between the TR
and CD25 TCR repertoires may relate to the mecha- can not be detected by our assay. Another possibility
is that self-antigen presentation to some TR TCRs cannisms that control TR development in the thymus. For
example, developing T cells may encounter a TR select- be spatially restricted such that the transferred T cells
do not gain sufficient access to these sites during theing ligand with only a certain probability or may stochas-
tically express a gene(s) critical for TR development, such 11 day window in our protocol. For example, adoptively
transferred T cells expressing low levels of CD62L mayas Foxp3 (Fontenot et al., 2003). Alternatively, it may
reflect the need for limiting non-TCR-derived signal(s). have limited trafficking through lymph nodes associated
with a particular organ, which serve as sites of presenta-These non-mutually exclusive hypotheses are consis-
tent with the report that only 50% of TCR transgenic tion of tissue-specific antigens by dendritic cells
(Scheinecker et al., 2002).T cells develop into TR, despite ubiquitous cognate anti-
gen expression in the thymus (Jordan et al., 2001). While the specific peptide ligands recognized by TR
TCRs remain to be identified, initial characterization ofWe have employed in vivo expansion in lymphopenic
hosts as the most sensitive assay for TCR interactions their specificity has suggested that TR TCRs recognize
MHC class II in a self-peptide-dependent manner, as TRwith self ligands. The avidity range of these interactions
may vary from relatively weak (“homeostatic”) to high TCRs failed to recognize in vitro APCs from previously
published CD22-dblo mice expressing primarily a single(“autoreactive”), although the threshold between these
levels cannot be easily distinguished. We use the term CD22 peptide:MHC class II complex (data not shown;
Barton et al., 2002). TR TCRs also failed to facilitateavidity here to represent the aggregate efficiency of
TCR-ligand interactions. Because the self ligands recog- in vivo expansion in TCR  Ii H-2M mice (Figure 4B),
which display a greatly reduced self peptide:MHC classnized by the CD25 TCRs are unknown, we cannot dis-
criminate between the contribution of increased TCR II repertoire (Kovats et al., 1998). What proteins are these
TR-reactive peptides derived from? Our analysis of prolif-affinity or higher self-peptide ligand abundance to the
overall TCR signal. The lack of expansion conferred by erative in vitro responses of TCli- RAG-deficient
T cells transduced with TR TRAV14 TCR chain librariesindividual CD25 TCRs (Figure 5) suggests a low fre-
quency of high-avidity TCR in this subset of cells com- showed reactivity to wild-type syngeneic MHC class II-
positive APCs, but also to Ii-deficient APCs, albeit at apared with the TR subset. We do believe that some of
the TR TCRs are autoreactive, as T cells transduced reduced level (Supplemental Figure S3A). Although we
cannot formally exclude the possibility that TR TCRs maywith a complex mixture of CD25 TCRs cause wasting
disease in lymphopenic hosts (Figure 3B). We have not, recognize antigens derived from commensal or patho-
genic flora or viruses, we believe that splenic APCs fromhowever, observed in vivo expansion of transduced
T cells in nonlymphopenic Ly5.1 hosts (data not B6 mice housed under strict SPF conditions are unlikely
to harbor class II bound peptides of microbial or viralshown), suggesting that their expansion is suppressed
by endogenous TR and/or their autoimmune potential is origin. Furthermore, Ii0 APCs are deficient in the presen-
tation of exogenous protein antigens, suggesting thatfacilitated by a lymphopenic environment (McHugh and
Shevach, 2002). Thus, our findings suggest that the avid- some TR TCRs may recognize peptides derived from
endogenously synthesized proteins displayed on Ii0ity of the majority of TR TCRs for self ligands is below
the range characteristic of conventional T cell responses APCs (Kovats et al., 1998). The recognition of ubiqui-
tously expressed self peptides by some TR TCRs doesto cognate antigens. This is consistent with the fact that
peripheral TR must have escaped negative selection in not exclude recognition of tissue-specific peptides by
others. In fact, we have found that adoptive transfer ofthe thymus.
Nonetheless, the differences that we observe in the TCli- RAG/ T cells transduced with a combination
of four CD25TCRs leads to peribronchiolitis and vascu-self-reactivity between CD25 and CD25 TCRs using
in vivo expansion in a lymphopenic hosts do appear to litis in the lungs of lymphopenic RAG1-deficient hosts
(data not shown). Although we cannot exclude the possi-have functional consequences for T cell development
(Figure 6). While a full evaluation of the role of TCR bility of ubiquitous antigen reactivity resulting in a tissue-
specific pathology (Matsumoto et al., 1999), these dataspecificity on regulatory T cell development is beyond
the scope of this manuscript, we do observe that individ- are suggestive of tissue-specific TR TCRs.
In summary, we have found that the CD25 CD4ual self-reactive CD25, but not nonreactive CD25,
TCRs facilitate generation, albeit at a varying degree, of TR TCR repertoire is as diverse as CD25 CD4 TCR
repertoire. By using TCR gene transfer, we have func-CD25-expressing T cells. However, the existing data do
not allow us to determine whether these naturally arising tionally assessed TR self-reactivity at a single TCR level
and found that the CD25, but not CD25, CD4 T cellTCRs are actively dictating a program of regulatory T cell
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Retroviral Transductionsubset exhibits a high frequency of TCRs with enhanced
MigR1-based retroviral vectors were transfected into the φNX-Eavidity against self peptides bound to MHC class II mole-
packaging cell line (Pear et al., 1993) using FuGENE 6 (Roche, India-cules expressed by peripheral APCs. This is consistent
napolis, IN). Culture medium was changed the following day, and
with the largely nonoverlapping TCR repertoires ob- virus was collected after culturing cells at 32C for 24–30 hr. TCli
served in these T cell subsets. This result further sug- RAG1 spleen and lymph node cells were stimulated for 24–30 hr
with 0.5–1 g ml1 of human CLIP in the presence of 20 U ml1gests that a large proportion of naturally arising TR rec-
human IL-2 (Roche) prior to a “spinfection” at 2500 RPM, 37C, forognize constitutively presented self ligands and is thus
90 min with 0.45 m filtered retroviral supernatant supplementedchronically stimulated. We speculate that this may be
with 4 g ml1 polybrene (Sigma, St. Louis, MO), IL-2 (20 U ml1), andimportant for providing a basal threshold for immune
HEPES 0.01 M. For T cells slated for in vivo experiments for relative
activation, which may then be dynamically regulated by expansion in Figures 4 and 5, less retroviral supernatant was used
the level of presentation of TR-specific self-antigens. to diminish the transduction efficiency. Cells were then cultured in
the presence of retroviral supernatant for another day, washed, and
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